| Authors: |
Black JRM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Karasaki T; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Department of Thoracic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Abbott CW; Personalis Inc., Fremont, CA, USA., Li B; Personalis Inc., Fremont, CA, USA., Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Al Bakir M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Department of Oncology, University College London Hospitals, London, UK., Liu WK; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Huebner A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Pawlik P; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK., Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Department of Cellular Pathology, University College London Hospitals NHS Foundation Trust, London, UK., Marinelli D; Department of Experimental Medicine, Sapienza University, Rome, Italy., Shutkever O; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Murphy C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Liu LY; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Grieco C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Grimes K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK., Navarro FCP; Personalis Inc., Fremont, CA, USA., Pyke RM; Personalis Inc., Fremont, CA, USA., Bartha G; Personalis Inc., Fremont, CA, USA., Keough KC; Personalis Inc., Fremont, CA, USA., Dea S; Personalis Inc., Fremont, CA, USA., Ravi N; Personalis Inc., Fremont, CA, USA., Lyle J; Personalis Inc., Fremont, CA, USA., Harris J; Personalis Inc., Fremont, CA, USA., Brown KD; The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Blackhall FH; The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, The University of Manchester, Manchester, UK., Hassani F; University Hospitals of Leicester NHS Trust, Leicester, UK., Fennell DA; University Hospitals of Leicester NHS Trust, Leicester, UK; University of Leicester, Leicester, UK., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK., Shaw JA; University of Leicester, Leicester, UK; NIHR Leicester Biomedical Research Centre, Leicester, UK., Abbosh C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; AstraZeneca, Cambridge, UK., Hackshaw A; Cancer Research UK, UCL Clinical Trials Centre, London, UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Department of Oncology, University College London Hospitals, London, UK; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Frankell AM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Early Cancer Institute, University of Cambridge, Cambridge, UK., Boyle SM; Personalis Inc., Fremont, CA, USA., Chen RO; Personalis Inc., Fremont, CA, USA., Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Department of Oncology, University College London Hospitals, London, UK. Electronic address: charles.swanton@crick.ac.uk. |
